Nuvation Bio, Inc. (NUVB)
5.14
-0.42
(-7.55%)
USD |
NYSE |
Oct 02, 16:00
5.17
+0.03
(+0.58%)
After-Hours: 20:00
Nuvation Bio Net Income (Quarterly) : -62.84M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.84M |
| March 31, 2026 | 5.397M |
| December 31, 2025 | -36.59M |
| September 30, 2025 | -55.79M |
| June 30, 2025 | -59.01M |
| March 31, 2025 | -53.24M |
| December 31, 2024 | -49.44M |
| September 30, 2024 | -41.21M |
| June 30, 2024 | -462.49M |
| March 31, 2024 | -14.79M |
| December 31, 2023 | -13.79M |
| September 30, 2023 | -19.65M |
| June 30, 2023 | -20.64M |
| Date | Value |
|---|---|
| March 31, 2023 | -21.73M |
| December 31, 2022 | -20.84M |
| September 30, 2022 | -27.20M |
| June 30, 2022 | -34.86M |
| March 31, 2022 | -21.29M |
| December 31, 2021 | -25.13M |
| September 30, 2021 | -21.98M |
| June 30, 2021 | -19.33M |
| March 31, 2021 | -20.40M |
| December 31, 2020 | -13.28M |
| September 30, 2020 | -11.03M |
| June 30, 2020 | -8.599M |
| March 31, 2020 | -8.746M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.316B |
| Johnson & Johnson | 5.534B |
| Pfizer Inc. | -246.00M |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 31.69M |
| Total Expenses (Quarterly) | 94.53M |
| EPS Diluted (Quarterly) | -0.1802 |
| Enterprise Value | 1.553B |
| Gross Profit Margin (Quarterly) | 68.42% |
| Profit Margin (Quarterly) | -198.3% |
| Earnings Yield | -8.47% |
| Normalized Earnings Yield | -8.179 |